466 related articles for article (PubMed ID: 23377573)
1. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
3. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis.
Szeto CC; Wang G; Chow KM; Lai FM; Ma TK; Kwan BC; Luk CC; Li PK
Clin Nephrol; 2015 Oct; 84(4):198-205. PubMed ID: 26308082
[TBL] [Abstract][Full Text] [Related]
4. Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.
Shankar PB; Nada R; Joshi K; Kumar A; Rayat CS; Sakhuja V
Diagn Pathol; 2014 Feb; 9():40. PubMed ID: 24559085
[TBL] [Abstract][Full Text] [Related]
5. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
6. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
7. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
8. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
9. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
10. Podocyte proteins in Galloway-Mowat syndrome.
Srivastava T; Whiting JM; Garola RE; Dasouki MJ; Ruotsalainen V; Tryggvason K; Hamed R; Alon US
Pediatr Nephrol; 2001 Dec; 16(12):1022-9. PubMed ID: 11793093
[TBL] [Abstract][Full Text] [Related]
11. Development of podocyte injuries in Osborne-Mendel rats is accompanied by reduced expression of podocyte proteins.
Yasuno K; Araki S; Sakashita H; Kobayashi R; Baba T; Kawakami H; Kamiie J; Ogihara K; Shirota K
J Comp Pathol; 2013; 149(2-3):280-90. PubMed ID: 23582971
[TBL] [Abstract][Full Text] [Related]
12. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
13. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.
Schmid H; Henger A; Cohen CD; Frach K; Gröne HJ; Schlöndorff D; Kretzler M
J Am Soc Nephrol; 2003 Nov; 14(11):2958-66. PubMed ID: 14569107
[TBL] [Abstract][Full Text] [Related]
15. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.
Kimura J; Ichii O; Otsuka S; Sasaki H; Hashimoto Y; Kon Y
Am J Nephrol; 2013; 38(1):27-38. PubMed ID: 23817053
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
17. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome.
Sharif K; Goyal M; Kershaw D; Kunkel R; Wiggins R
Exp Nephrol; 1998; 6(3):234-44. PubMed ID: 9639039
[TBL] [Abstract][Full Text] [Related]
18. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
19. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
20. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
